BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 36585187)

  • 21. SWATH mass spectrometry as a tool for quantitative profiling of the matrisome.
    Krasny L; Bland P; Kogata N; Wai P; Howard BA; Natrajan RC; Huang PH
    J Proteomics; 2018 Oct; 189():11-22. PubMed ID: 29501709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The in-silico zebrafish matrisome: A new tool to study extracellular matrix gene and protein functions.
    Nauroy P; Hughes S; Naba A; Ruggiero F
    Matrix Biol; 2018 Jan; 65():5-13. PubMed ID: 28739138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targets in the Tumour Matrisome to Promote Cancer Therapy Response.
    Jalil SMA; Henry JC; Cameron AJM
    Cancers (Basel); 2024 May; 16(10):. PubMed ID: 38791926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and characterization of a mouse prostate adenocarcinoma cell line: ductal formation determined by extracellular matrix.
    Jorcyk CL; Liu ML; Shibata MA; Maroulakou IG; Komschlies KL; McPhaul MJ; Resau JH; Green JE
    Prostate; 1998 Jan; 34(1):10-22. PubMed ID: 9428383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral bropirimine immunotherapy of rodent prostate cancer.
    Sarosdy MF
    Eur Urol; 1997; 31 Suppl 1():5-9. PubMed ID: 9076480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The composition of prostate core matrisome in vivo and in vitro unveiled by mass spectrometric analysis.
    Ojalill M; Rappu P; Siljamäki E; Taimen P; Boström P; Heino J
    Prostate; 2018 Jun; 78(8):583-594. PubMed ID: 29520855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of dimethylsulfoxide on the proliferation and glycosaminoglycan synthesis of rat prostate adenocarcinoma cells (PAIII) in vitro: isolation and characterization of DMSO-resistant cells.
    Kaneski CR; Constantopoulos G; Brady RO
    Prostate; 1991; 18(1):47-58. PubMed ID: 1987579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-tumor effect of the alphavirus-based virus-like particle vector expressing prostate-specific antigen in a HLA-DR transgenic mouse model of prostate cancer.
    Riabov V; Tretyakova I; Alexander RB; Pushko P; Klyushnenkova EN
    Vaccine; 2015 Oct; 33(41):5386-5395. PubMed ID: 26319744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rat PSP94 inhibits the growth and viability of the rat adenocarcinoma cell line PAIII in vitro.
    Cadieux PA; Mikolajczak SA; Reeves J; Strathdee C; Reid G; Panchal CJ; Clarke MW
    Cancer Invest; 2006; 24(3):246-55. PubMed ID: 16809150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices.
    Naba A; Clauser KR; Hoersch S; Liu H; Carr SA; Hynes RO
    Mol Cell Proteomics; 2012 Apr; 11(4):M111.014647. PubMed ID: 22159717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro model of metastasis to bone marrow mediates prostate cancer castration resistant growth through paracrine and extracellular matrix factors.
    Lescarbeau RM; Seib FP; Prewitz M; Werner C; Kaplan DL
    PLoS One; 2012; 7(8):e40372. PubMed ID: 22870197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pan-cancer analysis connects tumor matrisome to immune response.
    Bin Lim S; Chua MLK; Yeong JPS; Tan SJ; Lim WT; Lim CT
    NPJ Precis Oncol; 2019; 3():15. PubMed ID: 31123708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamic matrisome: ECM remodeling factors licensing cancer progression and metastasis.
    Yuzhalin AE; Lim SY; Kutikhin AG; Gordon-Weeks AN
    Biochim Biophys Acta Rev Cancer; 2018 Dec; 1870(2):207-228. PubMed ID: 30316942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure and Function of a Prostate Cancer Dissemination-Permissive Extracellular Matrix.
    Penet MF; Kakkad S; Pathak AP; Krishnamachary B; Mironchik Y; Raman V; Solaiyappan M; Bhujwalla ZM
    Clin Cancer Res; 2017 May; 23(9):2245-2254. PubMed ID: 27799248
    [No Abstract]   [Full Text] [Related]  

  • 35. Local intratumor immunotherapy of prostate cancer with interleukin-2 reduces tumor growth.
    Hautmann SH; Huland E; Huland H
    Anticancer Res; 1999; 19(4A):2661-3. PubMed ID: 10470215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of metastasis of circulating human prostate cancer cells in the chick embryo by an extracellular matrix produced by foreskin fibroblasts in culture.
    Menen R; Pinney E; Hassanein MK; Kolostova K; Bobek V; Suetsugu A; Zhang N; Bouvet M; Naughton GK; Hoffman RM
    Anticancer Res; 2012 May; 32(5):1573-7. PubMed ID: 22593434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tissue, age, sex, and disease patterns of matrisome expression in GTEx transcriptome data.
    Nieuwenhuis TO; Rosenberg AZ; McCall MN; Halushka MK
    Sci Rep; 2021 Nov; 11(1):21549. PubMed ID: 34732773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A matrisome RNA signature from early-pregnancy mouse mammary fibroblasts predicts distant metastasis-free breast cancer survival in humans.
    Ibrahim AM; Bilsland A; Rickelt S; Morris JS; Stein T
    Breast Cancer Res; 2021 Sep; 23(1):90. PubMed ID: 34565423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thalidomide promotes metastasis of prostate adenocarcinoma cells (PA-III) in L-W rats.
    Pollard M
    Cancer Lett; 1996 Mar; 101(1):21-4. PubMed ID: 8625277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The hepatic "matrisome" responds dynamically to injury: Characterization of transitional changes to the extracellular matrix in mice.
    Massey VL; Dolin CE; Poole LG; Hudson SV; Siow DL; Brock GN; Merchant ML; Wilkey DW; Arteel GE
    Hepatology; 2017 Mar; 65(3):969-982. PubMed ID: 28035785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.